KRYZA David

Fonction : Maitre de conférence

Spécialité :

Génie Pharmaceutique

Bureau : Rock

Téléphone : 04 78 78 29 06

EMail

32 documents

  • A.L. Giraudet, David Kryza, Aude Flechon. La TEP au 68Ga-PSMA et autres traceurs TEP. Médecine Nucléaire, Elsevier/Masson, 2017, 41 (3), pp.223-227. ⟨10.1016/j.mednuc.2017.02.013⟩. ⟨hal-02139034⟩
  • Aurélie Moreau, Anne Laure Giraudet, David Kryza, Françoise Borson-Chazot, Claire Bournaud-Salinas, et al.. FDOPA Patterns in Adrenal Glands. Clinical Nuclear Medicine, Lippincott, Williams & Wilkins, 2017, 42 (5), pp.379-382. ⟨10.1097/RLU.0000000000001636⟩. ⟨hal-02139123⟩
  • David Sarrut, Jean-Noël Badel, Adrien Halty, Gwenaelle Garin, David Perol, et al.. 3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma. EJNMMI Physics, Springer-Verlag, 2017, 4 (1), ⟨10.1186/s40658-016-0172-1⟩. ⟨hal-01446551⟩
  • Aurélie Moreau, Anne Giraudet, David Kryza, Françoise Borson-Chazot, Claire Bournaud, et al.. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT. Nuclear Medicine Communications, Lippincott, Williams & Wilkins, 2017, 38 (9), pp.771-779. ⟨10.1097/MNM.0000000000000708⟩. ⟨hal-02139119⟩
  • Imen Miladi, Marie-Thérèse Aloy, Emma Armandy, Pierre Mowat, David Kryza, et al.. Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma. Nanomedicine, Future Medicine, 2015, 11 (1), pp.147-157. ⟨10.1016/j.nano.2014.06.013⟩. ⟨hal-01053787⟩
  • Audrey Parat, David Kryza, Francoise Degoul, Jacqueline Taleb, Claire Viallard, et al.. Radiolabeled dendritic probes as tools for high in vivo tumor targeting: application to melanoma. Journal of materials chemistry‎ B, Royal Society of Chemistry, 2015, 3 (12), pp.2560-2571. ⟨10.1039/c5tb00235d⟩. ⟨hal-01814287⟩
  • Elisabeth Miot-Noirault, Aurélien Vidal, Jessica Morlieras, Pauline Bonazza, Philippe Auzeloux, et al.. Small rigid platforms functionalization with quaternary ammonium: Targeting extracellular matrix of chondrosarcoma. Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier, 2014, 10 (8), pp.1887-1895. ⟨10.1016/j.nano.2014.06.011⟩. ⟨hal-01115673⟩
  • A.L. Giraudet, J.N. Badel, Pierre Cassier, C. Desuzinges, S. Rey, et al.. Résultats préliminaires de la phase I avec 90Y-OTSA101-DTPA pour le traitement de synoviolosarcomes métastatiques. Médecine Nucléaire, Elsevier/Masson, 2014, 38 (3), pp.131. ⟨10.1016/j.mednuc.2014.03.018⟩. ⟨hal-02139037⟩
  • Jacqueline Taleb, Marc Janier, Pauline Bonazza, Patrick Roux, Imen Miladi, et al.. Radiation dose measurements for staff members involved in holmium-166 preclinical trial. Radiation Measurements, Elsevier, 2013, 58, pp.75-78. ⟨10.1016/j.radmeas.2013.08.007⟩. ⟨hal-02139104⟩
  • David Kryza, Marc Janier. Radio-UHPLC: A tool for rapidly determining the radiochemical purity of technetium-99m radiopharmaceuticals?. Applied Radiation and Isotopes, Elsevier, 2013, 78, pp.72-76. ⟨10.1016/j.apradiso.2013.04.005⟩. ⟨hal-02139249⟩